Safety of Janus kinase inhibitors, ustekinumab, and anti-interleukin-23 in older patients with immune-mediated diseases

Clinical Gastroenterology and Hepatology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles